Related Experiment Video
Updated: Jan 11, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Repeated fecal microbiota transplantation in dogs with chronic enteropathy can decrease disease activity and
Linda Toresson1,2, Ulrika Ludvigsson2, Gunilla Olmedal2
11Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX.
Repeated fecal microbiota transplantation (FMT) effectively treated chronic enteropathy (CE) in dogs, particularly those with mild dysbiosis. This approach reduced disease activity and corticosteroid dependence in refractory cases.
Area of Science:
- Veterinary Medicine
- Gastroenterology
- Microbiome Research
Background:
- Chronic enteropathy (CE) in dogs is a challenging condition often requiring advanced therapeutic strategies.
- Refractory CE cases present a significant clinical need for novel treatment options.
- Fecal microbiota transplantation (FMT) is emerging as a potential therapy for gastrointestinal disorders by modulating the gut microbiome.
Purpose of the Study:
- To evaluate the efficacy of repeated fecal microbiota transplantation (FMT) as an adjunctive treatment for dogs with refractory chronic enteropathy (CE).
- To assess clinical outcomes and fecal parameters, including dysbiosis index, bile acids, and calprotectin, following FMT.
- To identify predictors of response to repeated FMT in dogs with CE.
Main Methods:
- A prospective longitudinal observational study involving 39 dogs with refractory CE.
- Dogs received 2 to 3 rectal FMTs over one month.
- Clinical assessments using the Canine Inflammatory Bowel Disease Activity Index (CIBDAI) and fecal analyses were performed over a 6-month period.
Main Results:
- Twenty-eight of 39 dogs (71.8%) responded to FMT, with 13 achieving corticosteroid tapering.
- Long-lasting responders (LLRs) had significantly lower baseline dysbiosis index and higher percentages of secondary unconjugated fecal bile acids compared to non-responders.
- Dysbiosis index decreased significantly in LLRs after FMT, while clinical improvement was sustained for 6 months in this group.
Conclusions:
- Repeated FMT serves as an effective adjunctive treatment for refractory CE in dogs, especially those with minimal or moderate dysbiosis.
- Pre-existing marked dysbiosis and bile acid dysmetabolism may be associated with poor or transient responses to FMT.
- Further investigation into optimizing FMT protocols, potentially including repeated administrations, is warranted for non-responsive cases.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

